Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.35.5040
Full Text
Open PDFAbstract
Available in full text
Date
January 10, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)